Obstetric and Gynecologic Imaging

What Is the Best Initial Imaging for Fetal Anomaly Screening in a High-Risk Pregnancy?

·
What Is the Best Initial Imaging for Fetal Anomaly Screening in a High-Risk Pregnancy?

A 34-year-old G3P2 patient with pre-gestational diabetes presents at 19 weeks gestation for fetal anomaly screening. Her prior pregnancy was complicated by fetal growth restriction, and her first-trimester screening showed a borderline-high risk for trisomy 18. You know that a standard anatomy scan is routine, but given her multiple risk factors, you question if a more comprehensive initial study is warranted to provide the most accurate assessment and guide subsequent management. This article details the American College of Radiology (ACR) recommended imaging workflow for this specific clinical scenario: initial screening for fetal anomaly in a high-risk pregnancy. For this presentation, the ACR rates a `US pregnant uterus transabdominal detailed scan` as Usually Appropriate.

Who Fits This Clinical Scenario?

This guidance applies to pregnant patients in the second or third trimester who are considered high-risk and are undergoing their initial imaging evaluation for fetal anomalies. The definition of “high-risk” is crucial and includes a range of maternal and fetal factors that increase the a priori risk of a structural or chromosomal abnormality.

Inclusion criteria for this scenario include:

  • Advanced maternal age (typically defined as 35 years or older at delivery)
  • Pre-existing maternal conditions, such as diabetes mellitus, hypertension, or autoimmune disease
  • A personal or family history of a prior child with a congenital anomaly
  • Known or suspected fetal aneuploidy based on maternal serum screening or noninvasive prenatal testing (NIPT)
  • Exposure to known teratogenic medications or infections during pregnancy

This workflow is distinct from other common obstetric imaging scenarios. This guidance does not apply to:

  • Low-risk pregnancies: Patients without the risk factors listed above typically undergo a standard anatomy scan. This is covered in a separate ACR variant for low-risk initial screening.
  • Follow-up for known anomalies: If a prior ultrasound has already identified a major or minor (“soft marker”) anomaly, the imaging question is different. Those scenarios focus on characterizing a known finding, not initial screening, and are addressed in their own ACR workflows.

What Diagnoses Are You Working Up in This Scenario?

In a high-risk pregnancy, the pre-test probability for a range of fetal conditions is elevated. The detailed ultrasound serves as a comprehensive screening tool to detect or rule out these possibilities. The differential diagnosis is broad, encompassing both isolated structural defects and syndromes.

Major Structural Anomalies: These are the primary targets of the detailed scan. Congenital heart defects are the most common major congenital anomaly, and their incidence is significantly increased in patients with pre-gestational diabetes. The scan meticulously evaluates cardiac structures, including the four-chamber view and outflow tracts. Other critical systems assessed include the central nervous system for conditions like spina bifida and ventriculomegaly, the craniofacial structures for cleft lip/palate, the abdominal wall for gastroschisis or omphalocele, and the genitourinary system for renal agenesis or severe hydronephrosis.

Markers of Aneuploidy: While not diagnostic, certain ultrasound findings (often called “soft markers”) are associated with an increased risk for chromosomal abnormalities like trisomy 21, 18, or 13. A detailed scan is more sensitive for detecting these markers, which can include an increased nuchal fold, echogenic intracardiac focus, or pyelectasis. The presence or absence of these findings helps refine the risk assessment derived from serum screening or NIPT.

Fetal Growth Abnormalities: Maternal conditions like chronic hypertension and diabetes can impact placental function, leading to fetal growth restriction or macrosomia. The detailed scan includes biometry to assess fetal size and can provide an early indication of a growth trajectory that requires closer surveillance later in the pregnancy.

Why Is a US Pregnant Uterus Transabdominal Detailed Scan the Recommended Study?

The ACR designates a `US pregnant uterus transabdominal detailed scan` as Usually Appropriate for initial fetal anomaly screening in a high-risk pregnancy because it provides the necessary diagnostic depth that a standard scan may not. This study, often referred to as a targeted ultrasound or Level II scan, is a comprehensive anatomic survey performed by highly experienced personnel, typically in a maternal-fetal medicine (MFM) or specialized imaging center.

The key advantage of the detailed scan is its extended scope and the expertise of the operator. It includes all the components of a standard anatomy scan but adds more specific views of fetal structures, such as the cardiac outflow tracts, cerebellar vermis, and fetal hands and feet. This level of detail is crucial for detecting subtle anomalies that might be missed on a routine examination. Given the higher baseline risk in this patient population, starting with a more sensitive test is justified to avoid the false reassurance of a normal-appearing standard scan.

Alternative imaging studies are rated lower for this specific initial screening purpose:

  • US pregnant uterus transabdominal anatomy scan: This standard scan is rated May be appropriate (Disagreement). The disagreement highlights a key clinical decision point: while a standard scan is better than no scan, many experts believe it lacks the necessary sensitivity for a truly high-risk patient. Opting for a standard scan first may lead to delays in diagnosis if a subtle finding is missed, requiring a subsequent detailed scan anyway.
  • MRI fetal without IV contrast: This is also rated May be appropriate (Disagreement). Fetal MRI is a powerful problem-solving tool, not a screening modality. It is typically used after an ultrasound has identified a complex or poorly visualized anomaly, particularly of the brain or thorax. Using it for initial screening is inefficient and not indicated.

From a safety perspective, all recommended ultrasound modalities involve no ionizing radiation (0 mSv). Contrast is not used. An `MRI fetal without and with IV contrast` is rated Usually not appropriate due to concerns about the unknown long-term effects of gadolinium-based contrast agents on the developing fetus.

What’s Next After a Detailed Ultrasound? Downstream Workflow

The results of the detailed transabdominal ultrasound will dictate the subsequent management pathway, which often involves a multidisciplinary team.

  • If the study is positive for a major anomaly: The next steps are focused on definitive diagnosis, prognosis, and delivery planning. This typically involves an immediate consultation with a maternal-fetal medicine specialist and a pediatric subspecialist (e.g., pediatric cardiologist, neurosurgeon, or general surgeon). A fetal echocardiogram is almost always indicated for a suspected cardiac defect. Genetic counseling and discussion of invasive diagnostic testing, such as amniocentesis for karyotype or microarray, are essential to screen for associated chromosomal abnormalities.
  • If the study is negative (structurally normal fetus): This result is highly reassuring. However, the patient’s pregnancy remains high-risk due to the underlying maternal or historical factors. Management will focus on continued surveillance for complications like preeclampsia or fetal growth restriction, with serial growth ultrasounds often recommended later in the third trimester.
  • If the study is indeterminate or shows only soft markers: When views are suboptimal due to maternal body habitus or fetal positioning, a repeat scan in 1-3 weeks may be recommended. If isolated soft markers are found, the findings must be integrated with the results of aneuploidy screening (NIPT/serum screening) to generate a patient-specific risk. Genetic counseling is crucial to help the patient understand this revised risk and decide on further testing.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for fetal anomalies in a high-risk pregnancy requires careful attention to detail to avoid common missteps.

  • Vague Requisitions: Failing to provide specific clinical history (e.g., “pre-gestational diabetes,” “prior child with tetralogy of Fallot”) on the imaging order prevents the performing sonographer and physician from tailoring the examination to the specific risks.
  • Incorrect CPT Code: Ordering a standard anatomy scan (CPT 76805) when a detailed scan (CPT 76811) is indicated can result in an incomplete evaluation.
  • Suboptimal Timing: Performing the scan too early (before 18 weeks) or too late (after 22-24 weeks) can compromise visualization of key anatomical structures, particularly the heart. The ideal window is typically 18-22 weeks.
  • Ignoring Serum Screening: The ultrasound findings should always be interpreted in the context of prior NIPT or maternal serum screening results to provide the most accurate risk assessment for aneuploidy.

If a major structural anomaly is suspected or confirmed on the detailed ultrasound, immediate consultation with a maternal-fetal medicine specialist is the appropriate escalation.

Related ACR Topics and Tools

For a comprehensive overview of all clinical scenarios related to this topic, including low-risk screening and follow-up of identified abnormalities, please see the parent topic guide.

The following GigHz tools can also support your clinical workflow:

Frequently Asked Questions

What is the difference between a ‘standard’ anatomy scan and a ‘detailed’ scan?

A standard anatomy scan (CPT 76805) is a routine screening exam for low-risk pregnancies that assesses a required list of fetal structures. A detailed or targeted scan (CPT 76811) is more comprehensive, including all elements of the standard scan plus additional, more specific views of fetal anatomy, such as the cardiac outflow tracts. It is performed for high-risk indications and typically by personnel with advanced expertise in fetal imaging.

At what gestational age is this detailed scan best performed?

The optimal window for a detailed fetal anatomic survey is between 18 and 22 weeks gestation. During this period, the fetus is large enough for clear visualization of anatomical structures, but not so large that positioning and acoustic shadowing become significant limitations.

If the detailed ultrasound is normal, does that mean my pregnancy is no longer high-risk?

No. A normal detailed ultrasound is very reassuring regarding the absence of major structural anomalies, but it does not change the underlying maternal or historical factors that define the pregnancy as high-risk. The patient will still require continued surveillance for other potential complications, such as fetal growth restriction, preeclampsia, or gestational diabetes, based on her specific risk factors.

Why is fetal MRI not the first choice for screening in a high-risk pregnancy?

Fetal MRI is a powerful diagnostic tool, but it is not suited for screening. It is more expensive, less accessible, and more time-consuming than ultrasound. Its primary role is as a problem-solving modality to further evaluate a complex or uncertain finding that was first detected on an ultrasound, especially for anomalies of the central nervous system, lungs, or diaphragm.

Does a transvaginal ultrasound have a role in this second-trimester scenario?

While the primary screening is done transabdominally, a transvaginal ultrasound can be a useful adjunct in specific situations. It may be used to get better views of low-lying structures like the cervix, placenta previa, or parts of the fetal brain or spine when the fetus is in a breech position and deep in the pelvis. It is not used for the complete anatomic survey but rather to supplement the transabdominal approach when needed.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026